Abstract PS15-02: A Phase Ⅰb Study of D-0502 as Monotherapy for Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer: Results from the Dose-Expansion Stage

Jiayu Wang, Binghe Xu, Qingyuan Zhang et al.|Cancer Research|2024

Cited by 1